M

Medipost Co Ltd
KOSDAQ:078160

Watchlist Manager
Medipost Co Ltd
KOSDAQ:078160
Watchlist
Price: 24 400 KRW 2.09%
Market Cap: ₩956.5B

Net Margin

-133%
Current
Declining
by 98.4%
vs 3-y average of -34.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-133%
=
Net Income
₩-97.9B
/
Revenue
₩73.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-133%
=
Net Income
₩-97.9B
/
Revenue
₩73.6B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Medipost Co Ltd
KOSDAQ:078160
934.1B KRW
Loading...
US
CVS Health Corp
NYSE:CVS
93.3B USD
Loading...
US
Cigna Group
XMUN:CGN
60.5B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.9B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.4B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...

Market Distribution

Lower than 95% of companies in Korea
Percentile
5th
Based on 2 632 companies
5th percentile
-133%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Medipost Co Ltd
Glance View

Market Cap
956.5B KRW
Industry
Health Care

Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2005-07-29. The firm mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoietic stem cell transplantation (HSCT) as a result of blood-related diseases, such as leukemia or aplastic anemia, as well as family cord blood bank, which provides services for storing newborn’s cord blood exclusively for family’s use. The company also involves in the provision of stem cell drugs, which are used for recovery of knee articular cartilage and others, distribution of healthcare food and natural cosmetics, as well as provision of healthcare services.

Intrinsic Value
5 409.64 KRW
Overvaluation 78%
Intrinsic Value
Price
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-133%
=
Net Income
₩-97.9B
/
Revenue
₩73.6B
What is Medipost Co Ltd's current Net Margin?

The current Net Margin for Medipost Co Ltd is -133%, which is below its 3-year median of -34.7%.

How has Net Margin changed over time?

Over the last 3 years, Medipost Co Ltd’s Net Margin has decreased from 4.4% to -133%. During this period, it reached a low of -137.3% on Jun 30, 2025 and a high of 27.2% on Jun 30, 2023.

Back to Top